Novocure limited (NVCR)
Income statement / Quarterly
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Sep'14
Net revenues

101,828

99,234

92,062

86,713

73,309

69,674

64,756

61,514

52,125

53,661

50,109

38,376

34,880

30,242

21,674

17,919

13,053

12,383

8,953

6,543

5,208

4,374

Cost of revenues

24,496

24,786

22,900

21,106

19,814

23,028

18,949

19,833

18,238

15,641

15,153

13,152

11,664

10,973

11,118

9,797

7,982

6,304

5,659

4,750

3,897

2,586

Impairment of field equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

6,412

-

-

-

-

-

-

Gross profit

77,332

74,448

69,162

65,607

53,495

46,646

45,807

41,681

33,887

38,021

34,956

25,224

23,216

19,269

10,556

1,710

5,071

6,079

3,294

1,793

1,311

1,788

Operating costs and expenses:
Research, development and clinical trials

25,271

23,741

18,766

19,454

17,042

15,034

13,074

11,362

11,104

10,048

9,273

9,371

9,411

8,471

10,233

11,318

11,445

10,845

10,211

12,765

9,927

9,276

Sales and marketing

28,834

26,804

23,830

23,708

22,333

21,208

19,124

19,196

18,135

16,025

16,387

16,360

14,756

15,678

15,865

14,598

13,308

14,724

8,916

8,866

6,355

5,384

General and administrative

26,608

23,750

22,711

21,249

20,238

19,068

18,855

18,208

17,325

16,454

15,215

15,023

12,422

12,997

12,723

13,031

12,256

11,116

8,405

7,368

6,975

5,033

Total operating costs and expenses

80,713

74,295

65,307

64,411

59,613

55,310

51,053

48,766

46,564

42,527

40,875

40,754

36,589

37,146

38,821

38,947

37,009

36,685

27,532

28,999

23,257

19,693

Operating income (loss)

-3,381

153

3,855

1,196

-6,118

-8,664

-5,246

-7,085

-12,677

-4,506

-5,919

-15,530

-13,373

-17,877

-28,265

-37,237

-31,938

-30,606

-24,238

-27,206

-21,946

-17,905

Financial expenses (income), net

2,432

1,745

2,555

1,239

2,371

2,160

2,397

2,860

4,853

2,384

2,156

2,183

2,446

2,854

2,189

555

549

875

809

876

591

53

Income (loss) before income tax

-5,813

-1,592

1,300

-43

-8,489

-10,824

-7,643

-9,945

-17,530

-6,890

-8,075

-17,713

-15,819

-20,731

-30,454

-37,792

-32,487

-31,481

-25,047

-28,082

-22,537

-17,958

Income tax

-9,765

-5,852

-630

1,227

3,661

4,807

4,051

5,565

3,194

4,055

3,423

3,461

2,226

1,437

3,174

2,820

2,950

1,447

976

1,275

736

362

Net income (loss)

3,952

4,260

1,930

-1,270

-12,150

-15,631

-11,694

-15,510

-20,724

-10,945

-11,498

-21,174

-18,045

-22,168

-33,628

-40,612

-35,437

-32,928

-26,023

-29,357

-23,273

-18,320

Basic net income (loss) per ordinary share (in usd per share)

0.04

-

0.02

-

-0.13

-

-0.13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of ordinary shares used in computing basic net income (loss) per share (in shares)

99,877

-

98,485

-

94,811

-

92,911

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Diluted net income (loss) per ordinary share (in usd per share)

0.04

-

0.02

-

-0.13

-

-0.13

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Weighted average number of ordinary shares used in computing diluted net income (loss) per share (in shares)

108,100

-

107,604

-

94,811

-

92,911

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Basic and diluted net income (loss) per ordinary share (in usd per share)

-

-

-

-0.01

-

-

-

-0.17

-0.23

-0.12

-0.13

-0.24

-0.21

-0.25

-0.39

-0.48

-0.42

2.55

-2.09

-2.36

-1.77

-1.45

Weighted average number of ordinary shares used in computing basic and diluted net income (loss) per share (in shares)

-

-

-

96,356

-

-

-

91,331

89,985

89,389

89,125

88,218

87,452

86,787

85,774

85,274

84,397

83,607

12,431

12,427

13,140

12,594